Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2024-11-05 Capital/Financing Update
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing a correction (정정신고) to a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It outlines specific changes to call option terms and other investment details. Since this document relates to company financing and capital structure changes, it falls under the 'Capital/Financing Update' category.
2024-11-05 Korean
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Bioplus) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to investment amounts and timelines. Since this relates to capital expenditure and financing/investment activities, it falls under the 'Capital/Financing Update' category.
2024-10-18 Korean
[첨부추가]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Bioplus regarding a 'New Facility Investment' (신규시설투자). It details the investment amount, purpose (Eumseong Bio Complex), and board approval date. Since this is a specific corporate announcement regarding capital expenditure and facility investment, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, share issuance, or financial reports.
2024-10-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of major shareholders (Jung Hyun-kyu and special related parties) in BioPlus Co., Ltd., including changes in share pledges for tax collateral. This falls under the category of Major Shareholding Notification (MRQ).
2024-10-10 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Contract' (신탁계약등에의한취득상황보고서) filed by BioPlus Co., Ltd. with the Financial Supervisory Service (FSS). It details the company's share buyback activities conducted through a trust agreement with Korea Investment & Securities. Since the document reports the company's own share transactions (buybacks) via a trust, it falls under the category of 'Transaction in Own Shares'.
2024-09-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, specifically noting the resignation of an executive (special related party) as the reason for the change. This falls under the category of Major Shareholding Notification.
2024-09-06 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.